Tobii Dynavox TD Navio Maxi Speech Generating Device Recall Over Battery Mounting Tabs Damage

Source: FDA · United States

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

Tobii Dynavox Llc is recalling certain TD Navio Maxi Speech Generating Devices because damaged battery mounting tabs may allow the battery to move and cause an internal short circuit.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on September 10, 2026 and geographically references United States. The FDA classifies this as a Class II recall, with the stated reason "Under certain conditions, the battery mounting tabs may become damaged, allowing the battery to move within the device enclosure, potentially leading to an internal short circuit. This may cause localized heating and gas venting within the device enclosure.", distributed us nationwide distribution.. FDA recall classes run from I (reasonable probability of serious harm) to III (unlikely to cause harm), so the class number is the fastest way to gauge severity here. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.

Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Medical Device.

What Happened

Tobii Dynavox Llc initiated a voluntary recall of the TD Navio Maxi Speech Generating Device after determining that under certain conditions the battery mounting tabs may become damaged. This can allow the battery to move within the device enclosure, potentially leading to an internal short circuit that may cause localized heating and gas venting.

Which Products Are Affected

The recall covers the TD Navio Maxi Speech Generating Device, Model/Catalog Number 1000799, with UDI-DI 073400747602070 and serial numbers TDNL1-240904000016 through TDNL1-260617070001. The recall affects devices distributed nationwide in the United States under FDA recall number Z-2960-2026. Corrected units use new serialization beginning with TDNL1-260617070001.

What You Should Do

Consumers should verify the serial number of their device against the affected range. The recalling firm notified customers by letter; affected users should follow instructions provided in the notification or contact Tobii Dynavox Llc for return or remediation guidance.

Why This Matters

This Class II recall addresses a defect that could result in device malfunction involving localized heating and gas venting.

Source

FDA Enforcement Report, recall number Z-2960-2026, Tobii Dynavox Llc.

Original source: FDA Official Notice ↗

All FDA Recalls →

Nationwide notices with similar length or severity timing 8

Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
Tobii Dynavox Llc is recalling certain TD Navio Maxi Speech Generating Devices because damaged battery mounting tabs may allow the battery to move and cause an internal short circuit.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How is this recall classified, and why does that matter?
The FDA classifies this as a Class II recall, citing "Under certain conditions, the battery mounting tabs may become damaged, allowing the battery to move within the device enclosure, potentially leading to an internal short circuit. This may cause localized heating and gas venting within the device enclosure." as the reason. Class I is the most serious (reasonable probability of serious harm), Class II is a moderate or temporary health risk, and Class III is unlikely to cause harm.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.